Wednesday, February 10, 2010, 1:02am EST - Canadian Markets open in 8 hours and 28 minutes.
To create a watchlist or portfolio of shares, Sign-in or Register

Pharmasset, Inc. (VRUS)

 On Feb 9: 22.68 USD  Up 0.40 (1.80%)  
MORE ON VRUS
Quotes
HereSummary
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
Pharmasset, Inc. (NGM:VRUS) Delayed quote dataEdit
After Hours: 22.68 0.00 (0.00%) as of 4:34pm EST on 02/09/10
Last Trade: 22.68 USD
Trade Time: Feb 9
Change: Up 0.40 (1.80%)
Prev Close: 22.28
Open: 22.21
Bid: N/A
Ask: 23.50 x 2500
1y Target Est: 27.67
Day's Range: 22.14 - 23.00
52wk Range: 7.62 - 24.61
Volume: 210,688
Avg Vol (3m): 145,808
Market Cap: 641.32M
P/E (ttm): N/A
EPS (ttm): -2.10
Div & Yield: N/A (N/A%)
Pharmasset, Inc. (VRUS)
1d  5d  3m  6m  1y  2y  5y 
 Add VRUS to Portfolio   Download Data

HEADLINES
• PHARMASSET INC Files SEC form 10-Q, Quarterly Report
EDGAR Online (Tue 4:24pm)
• InPlay: Pharmasset reports 1Q10 results
Briefing.com (Tue 4:16pm)
• Pharmasset Reports Fiscal First Quarter 2010 Financial Results
PRNewswire (Tue 4:00pm)
• Pharmasset Announces Exercise of Underwriter's Option
PRNewswire (Fri, Jan 29)
• PHARMASSET INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits
EDGAR Online (Thu, Jan 28)
• Pharmasset Prices Underwritten Offering of Common Stock
PRNewswire (Thu, Jan 28)
• Pharmasset Announces Proposed Public Offering of Common Stock
PRNewswire (Wed, Jan 27)
• PHARMASSET INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits
EDGAR Online (Mon, Jan 25)
• Pharmasset Initiates Phase 2a Trial with PSI-7977, a Chirally Pure Isomer of PSI-7851
PRNewswire (Thu, Jan 21)
• Pharmasset to Present at the 28th Annual JPMorgan Healthcare Conference
PRNewswire (Fri, Jan 8)
More Headlines for VRUS...
ANALYST
EPS Est (next year) (Sep-10) : -1.59
EPS Est (in 2 years) (Sep-11) : -1.29
Avg Rec (current)*: 1.4
PEG Ratio: N/A
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

BUSINESS SUMMARY
Pharmasset, Inc., a clinical-stage pharmaceutical company, focuses on discovering, developing, and commercializing novel drugs to treat viral infections.

Full Company Profile

Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Symbol Lookup
• Latest News • Canadian Indices